|Day Low/High||218.47 / 220.81|
|52 Wk Low/High||156.85 / 236.86|
I have the answer, and it's something I learned as a rookie nearly four decades ago.
I just love the sheer aggression, and the open willingness to remodel what had been a very successful industrial conglomerate.
All in all stick with the tipping pointers, they are the drivers of this and the next leg higher.
Put HON on your 'return-to-normal' list of stocks.
I will come back to these names over and over again as we are now in the sweet spot for many.
As the Dow hits an all-time high while a pandemic rages on, who are those willing to look through the valley to the good numbers?
Many CEOs disagreed with a number of Trump's positions and are looking forward to a new, more predictable regime.
We are going to win the war, but battles are still ahead. Here's how to invest in the meantime.
Plus, we check out up the bevy of reasons for this week's negative market behavior.
I don't pick stocks on politics, but was shocked to see how a majority of our Action Alerts PLUS holdings would perform if Joe Biden wins the White House.
Here's what to do when you get a number of charts of companies like General Electric, 3M and Honey that are bullish.
The research firms today put something in context that seems almost impossible: we are having a boom in the goods side, not the service side.
Plus, Kansas City Southern rejects a reported takeover overture.
How September markets digest August ahead of momentous events will be far more important to uptrend maintenance than how August closed.
Apple's weight in the (price-weighted) Dow Jones Industrial Average, effective this morning, will be reduced from 12% to 3% -- based on the company's 4-1 stock split. In response to that split, Amgen , Honeywell , and Salesforce are being added to t...
Traders and investors could go long HON as it joins the DJIA club.
Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
What I see: This stock responds well to economic recovery.
Monday's market action was in no way similar to that recent disparity between the 'haves' and 'have nots.'
"I am going to write a good Diary on Real Money Pro today... and I am going to help people. Because I am good enough, I am smart enough and doggone it, people like me." - Daily Affirmations with Dougie Kass Today's Affirmations is about fame and how...
But that's exactly where we are right now, in this third day of the rotation, so here's your path to safety.
Plus, why shares of vaccine maker Moderna are taking a hit.
Next week the June quarter earnings season maelstrom kicks off with 115 companies, including 32 S&P 500 constituents, reporting their latest quarterly results. In recent days we've seen a number of companies up their outlook for the quarter but we'v...
While the fundamental story on HON may sound promising, the charts and indicators tell a different story.
Let's go over the confluence that allowed us to advance after a brief dip down in the morning.
We're cheering what may be an aberration, a bullish employment number. We'll take what it brings - a wholesale shift in what we're buying and what we're selling to fund it.